| Material Contracts and Documents | Details/Actions |
|---|---|
| A. Material Contracts for the Issue | |
| 1. Issue Agreement dated May 09, 2024 between our Company and the Lead Manager. | View Page |
| 2. Registrar Agreement dated April 04, 2024, between our Company and the Registrar to the Issue. | View Page |
| 3. Banker to the Issue Agreement dated May 09, 2024 between our Company, the Lead Manager, the Registrar to the Issue and the Banker to the Issue. | View Page |
| 4. Monitoring Agency Agreement dated May 09, 2024 between our Company and the Monitoring Agency. | View Page |
|
B. Material Documents |
|
| 1. Certified copies of the Memorandum of Association and Articles of Association of our Company as amended. | View Page |
| 2. Certificate of incorporation dated February 23, 2017, issued by Registrar of Companies, Central Registration Centre. | View Page |
| 3.Certificate of incorporation pursuant to change of name dated March 25, 2017, issued by the RoC. | View Page |
| 4. Annual Reports of our Company for Fiscal 2023, Fiscal 2022, Fiscal 2021, Fiscal 2020 and Fiscal 2019. | Download Zip |
| 5.Resolutions of our Board of Directors dated July 05, 2023, approving the Issue. | View Page |
| 6.Resolutions of our Rights Issue Committee dated May 09, 2024 approving this Letter of Offer, finalizing the terms of the Issue including Issue Price, Record Date and the Rights Entitlement Ratio. | View Page |
| 7. The Annual Financial Statements and Unaudited Interim Financial Statements along with reports dated May 12, 2023 and February 14, 2024, respectively, of the Statutory Auditors thereon include | View Page |
| 8.Statement of special tax benefits dated April 22, 2024, issued by M/s Mahesh C. Solanki & Co, Independent Chartered Accountants, for our Company and its shareholders. | View Page |
| 9. Consents of our Directors, Company Secretary and Compliance Officer, the Chief Financial Officer, the Statutory Auditors, Lead Manager, Banker to the Issue, Legal Advisor to the Issue, the Registrar to the Issue, the Monitoring Agency and the Independent Chartered Accountant for inclusion of their names in their respective capacities. | Download Zip |
| 10. Consent letter dated April 24, 2024, from our Statutory Auditors, Deloitte Haskins & Sells LLP, Chartered Accountants to include their name in this Letter of Offer, as an “expert” as defined under Section 2(38) of the Companies Act, in respect of their (i) Annual Financial Statements; (ii) Unaudited Interim Financial Statements, included in this Letter of Offer. However, the term “expert” and the consent thereof shall not be construed to mean an “expert” or consent within the meaning as defined under the Securities Act. | Download Zip |
| 11. Consent letter dated April 22, 2024, for our Independent Chartered Accountants, M/s Mahesh C. Solanki & Co, to include their name in this Letter of Offer, as an “expert” as defined under Section 2(38) of the Companies Act. | View Page |
| 12. Consent letter dated April 22, 2024, from the Chartered Engineer, M Ravichandran, to include his name in this Letter of Offer, as an “expert” as defined under Section 2(38) of the Companies Act. | View Page |
| 13. Certificate dated April 22, 2024, prepared and issued by the chartered engineer namely, M Ravichandran. | View Page |
| 14. Report titled “Industry Research Report on API (Pharma) Industry” prepared and issued by CareEdge Research published in February 2024. | View Page |
| 15. Tripartite Agreement dated February 21, 2020, entered between our Company, Registrar to the Issue and NSDL. | View Page |
| 16.Tripartite Agreement dated February 20, 2020, entered between our Company, Registrar to the Issue and CDSL. | View Page |
| 17. Due Diligence Certificate dated May 09, 2024 addressed to SEBI from the Lead Manager. | View Page |
| 18. In-principle listing approvals dated May 06, 2024 and May 02, 2024, issued by BSE and NSE, respectively. | View Page |
